A CUTANEOUS ADVERSE EFFECTS IN COVID-19 VACCINE
DOI:
https://doi.org/10.29303/jku.v11i4.777Kata Kunci:
Vaksin, COVID-19, Efek Samping, KulitAbstrak
Pada Bulan Maret 2020, World Health Organization (WHO) mengumumkan Penyakit COVID-19 sebagaiPandemi. Vaksin adalah produk biologis yang dapat digunakan untuk menginduksi respon imun tubuh yang kemudian dapat memberikan perlindungan terhadap infeksi dan/atau penyakit pada paparan patogen, oleh karena itu, vaksinasimenjadi salah satu kunci pencegahan dan pemutusan rantai penyebaran COVID-19. Berdasarkan hasil uji klinis, vaksinCOVID-19 menunjukkan kadar imunogenisitas yang cukup menjanjikan dengan berbagai persentase efektivitas dantingkat keamanan yang cukup baik. Dengan dilaksanakannya vaksinasi di seluruh dunia, mulai bermunculan laporanefek samping derajat sedang hingga berat. Efek samping mukokutaneus penting untuk diperhatikan karena dapatterlihat secara kasat mata dan memiliki potensi menimbulkan rasa takut pada individu dan lingkungan sekitar, serta mengakibatkan keengganan masyarakat untuk melakukan vaksinasi.
Referensi
1. Özdemir Ö. Coronavirus Disease 2019 (COVID-19): Diagnosis and Management (narrative review). Erciyes Medical Journal. Published online 2020. doi:10.14744/etd.2020.99836
2. Susilo A, Martin Rumende C, Pitoyo CW, et al. TINJAUAN PUSTAKA. Vol 7.; 2020. https://www.ncbi.nlm.nih.gov/nuccore/
3. da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wiener Klinische Wochenschrift. 2021;133(7-8):377-382. doi:10.1007/s00508-020-01760-4
4. Callaway Ewen, Cyranoski David, Mallapaty Smriti, Stoye Emma, Tollefson Jeff. Coronavirus By The Numbers. Springer Nature. 2020;579.
5. Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines: Effects of COVID-19 vaccines. Clinics in Dermatology. 2021;39(3):523-531. doi:10.1016/j.clindermatol.2021.04.001
6. Kementrian Kesehatan, ITAGI, WHO, UNICEF. Survei Penerimaan Vaksin COVID- 19 Di Indonesia. Published online 2020:1-26.
7. Yan Z, Yang M, Lai CL. Covid-19 vaccines: A review of the safety and efficacy of current clinical trials. Pharmaceuticals. 2021;14(5). doi:10.3390/ph14050406
8. Elgendy MO, El-Gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population. Vaccines (Basel). 2022;10(1). doi:10.3390/vaccines10010109
9. Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In: ; 2020:23-31. doi:10.1007/978-981-15-4814-7_3
10. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021 Feb;21(2):83-100. doi: 10.1038/s41577-020- 00479-7. Epub 2020 Dec 22. Erratum in: Nat Rev Immunol. 2021 Jan 5;: PMID: 33353987; PMCID: PMC7754704.
11. Escobar A, Reyes-López FE, Acevedo ML, Alonso-Palomares L, Valiente-Echeverría F, Soto-Rifo R, et al. Evaluation of the Immune Response Induced by CoronaVac 28- Day Schedule Vaccination in a Healthy Population Group. Front Immunol. 2022;12(January):1–8.
12. Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med.2021 Sep 2;385(10):875–84.
13. Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, et al. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine. N Engl J Med. 2021 Sep 23;385(13):1172–83.
14. Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the Main Anti- SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety. Infect Drug Resist. 2021 Aug;Volume 14:3459–76.
15. Bettini E, Locci M. SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond. Vaccines. 2021 Feb 12;9(2):147.
16. Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID-19 Vaccination- Induced Rash: Does the Choice of Vaccine Matter? Cureus. 2021 Jun 7;
17. Hatami P, Aryanian Z, Asl HN, Goodarzi A. Mucocutaneous adverse effects following COVID-19 vaccination: a case series with a comprehensive review of the literature. Vol. 24, Iranian Journal of Dermatology. Iranian Society of Dermatology; 2021. p. 331–8.
18. Tan SW, Tam YC, Pang SM. Cutaneous reactions to COVID-19 vaccines: A review. JAAD International. 2022 Jun 1;7:178–86.
19. Gisondi P, Bellinato F, Girolomoni G. Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. Vol. 36, Journal of the European Academy of Dermatology and Venereology. John Wiley and Sons Inc; 2022. p. 165–6.
20. Benyamna Y, Marraha F, al Faker I, Chahoub H, Rahmani N, Rkiek Y, et al. Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination. Case Reports in Dermatological Medicine. 2022;2022.
21. Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with sars?cov?2 vaccines. Vol. 10, Journal of Clinical Medicine. MDPI; 2021.
22. Picone V, Martora F, Fabbrocini G, Marano L. “Covid arm”: Abnormal side effect after Moderna COVID-19 vaccine. Vol. 35, Dermatologic Therapy. John Wiley and Sons Inc; 2022.
23. Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, et al. SARS- CoV-2 vaccine-related cutaneous manifestations: a systematic review. International Journal of Dermatology. John Wiley and Sons Inc; 2022.
24. Choi E, Liew CF, Oon HH. Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian country. Vol. 34, Dermatologic Therapy. John Wiley and Sons Inc; 2021.
25. Qaderi K, Golezar MH, Mardani A, Mallah MA, Moradi B, Kavoussi H, et al. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review. Vol. 35, Dermatologic Therapy. John Wiley and Sons Inc; 2022.
26. Klimek L, Bergmann KC, Brehler R, Pfützner W, Zuberbier T, Hartmann K, et al. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Allergo Journal International. 2021 May 1;30(3):79–95.
27. Rice SM, Ferree SD, Mesinkovska NA, Kourosh AS. The art of prevention: COVID-19 vaccine preparedness for the dermatologist. Vol. 7, International Journal of Women’s Dermatology. Elsevier Inc.; 2021. p. 209–12.
2. Susilo A, Martin Rumende C, Pitoyo CW, et al. TINJAUAN PUSTAKA. Vol 7.; 2020. https://www.ncbi.nlm.nih.gov/nuccore/
3. da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wiener Klinische Wochenschrift. 2021;133(7-8):377-382. doi:10.1007/s00508-020-01760-4
4. Callaway Ewen, Cyranoski David, Mallapaty Smriti, Stoye Emma, Tollefson Jeff. Coronavirus By The Numbers. Springer Nature. 2020;579.
5. Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines: Effects of COVID-19 vaccines. Clinics in Dermatology. 2021;39(3):523-531. doi:10.1016/j.clindermatol.2021.04.001
6. Kementrian Kesehatan, ITAGI, WHO, UNICEF. Survei Penerimaan Vaksin COVID- 19 Di Indonesia. Published online 2020:1-26.
7. Yan Z, Yang M, Lai CL. Covid-19 vaccines: A review of the safety and efficacy of current clinical trials. Pharmaceuticals. 2021;14(5). doi:10.3390/ph14050406
8. Elgendy MO, El-Gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population. Vaccines (Basel). 2022;10(1). doi:10.3390/vaccines10010109
9. Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In: ; 2020:23-31. doi:10.1007/978-981-15-4814-7_3
10. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021 Feb;21(2):83-100. doi: 10.1038/s41577-020- 00479-7. Epub 2020 Dec 22. Erratum in: Nat Rev Immunol. 2021 Jan 5;: PMID: 33353987; PMCID: PMC7754704.
11. Escobar A, Reyes-López FE, Acevedo ML, Alonso-Palomares L, Valiente-Echeverría F, Soto-Rifo R, et al. Evaluation of the Immune Response Induced by CoronaVac 28- Day Schedule Vaccination in a Healthy Population Group. Front Immunol. 2022;12(January):1–8.
12. Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med.2021 Sep 2;385(10):875–84.
13. Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, et al. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine. N Engl J Med. 2021 Sep 23;385(13):1172–83.
14. Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the Main Anti- SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety. Infect Drug Resist. 2021 Aug;Volume 14:3459–76.
15. Bettini E, Locci M. SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond. Vaccines. 2021 Feb 12;9(2):147.
16. Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID-19 Vaccination- Induced Rash: Does the Choice of Vaccine Matter? Cureus. 2021 Jun 7;
17. Hatami P, Aryanian Z, Asl HN, Goodarzi A. Mucocutaneous adverse effects following COVID-19 vaccination: a case series with a comprehensive review of the literature. Vol. 24, Iranian Journal of Dermatology. Iranian Society of Dermatology; 2021. p. 331–8.
18. Tan SW, Tam YC, Pang SM. Cutaneous reactions to COVID-19 vaccines: A review. JAAD International. 2022 Jun 1;7:178–86.
19. Gisondi P, Bellinato F, Girolomoni G. Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. Vol. 36, Journal of the European Academy of Dermatology and Venereology. John Wiley and Sons Inc; 2022. p. 165–6.
20. Benyamna Y, Marraha F, al Faker I, Chahoub H, Rahmani N, Rkiek Y, et al. Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination. Case Reports in Dermatological Medicine. 2022;2022.
21. Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with sars?cov?2 vaccines. Vol. 10, Journal of Clinical Medicine. MDPI; 2021.
22. Picone V, Martora F, Fabbrocini G, Marano L. “Covid arm”: Abnormal side effect after Moderna COVID-19 vaccine. Vol. 35, Dermatologic Therapy. John Wiley and Sons Inc; 2022.
23. Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, et al. SARS- CoV-2 vaccine-related cutaneous manifestations: a systematic review. International Journal of Dermatology. John Wiley and Sons Inc; 2022.
24. Choi E, Liew CF, Oon HH. Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian country. Vol. 34, Dermatologic Therapy. John Wiley and Sons Inc; 2021.
25. Qaderi K, Golezar MH, Mardani A, Mallah MA, Moradi B, Kavoussi H, et al. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review. Vol. 35, Dermatologic Therapy. John Wiley and Sons Inc; 2022.
26. Klimek L, Bergmann KC, Brehler R, Pfützner W, Zuberbier T, Hartmann K, et al. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Allergo Journal International. 2021 May 1;30(3):79–95.
27. Rice SM, Ferree SD, Mesinkovska NA, Kourosh AS. The art of prevention: COVID-19 vaccine preparedness for the dermatologist. Vol. 7, International Journal of Women’s Dermatology. Elsevier Inc.; 2021. p. 209–12.
Unduhan
Diterbitkan
2022-12-30
Cara Mengutip
Nadeak, B. Y., Keneyzia Carla Gliselda, Budiyarto, L. ., & Zulkifly, F. . (2022). A CUTANEOUS ADVERSE EFFECTS IN COVID-19 VACCINE. Baphomet University : Situs Slot Online Gacor Terbaik Hari Ini Server Thailand Gampang Maxwin 2024, 11(4), 1219–1227. https://doi.org/10.29303/jku.v11i4.777
Terbitan
Bagian
Tinjauan Pustaka
